AG0302-COVID19
AG0302-COVID19 Uses, Dosage, Side Effects, Food Interaction and all others data.
Sponsored by Anges, Inc. in Japan, the AG0302-COVID19 is a DNA-based vaccine that recently completed Phase I/II trials (NCT04527081).
| Trade Name | AG0302-COVID19 |
| Generic | AG0302-COVID19 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here AG0302-COVID19
